Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CAPN9 | O14815 | 1/20 | 0.38 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | PPM1B | O75688 | 1/20 | 0.33 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.33 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.33 |
| ▸ | PPP1CC | P36873 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 4/20 | 0.33 |
| ▸ | CA1 | P00915 | 4/20 | 0.33 |
| ▸ | CA2 | P00918 | 4/20 | 0.33 |
| ▸ | CA9 | Q16790 | 3/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13359047 | 0.83 | CAPN9 (0.39) | CAPN9TRPM8ALDH1A1MAPTPPM1B | |
| SCHEMBL25472089 | 0.82 | PPM1B (0.36) | CAPN9ALDH1A1MAPTMEN1KMT2A | |
| SCHEMBL30242828 | 0.82 | PPM1B (0.36) | CAPN9ALDH1A1MAPTMEN1KMT2A | |
| SCHEMBL30242933 | 0.80 | PPM1B (0.37) | CAPN9ALDH1A1MAPTMEN1KMT2A | |
| SCHEMBL24198158 | 0.80 | PPM1B (0.37) | CAPN9ALDH1A1MAPTMEN1KMT2A | |
| SCHEMBL16306571 | 0.78 | PPM1B (0.40) | ALDH1A1MAPTMEN1KMT2APPM1B | |
| SCHEMBL10595744 | 0.78 | PPM1B (0.41) | TRPM8ALDH1A1MAPTMEN1CYP1A2 | |
| SCHEMBL7266782 | 0.77 | ALDH1A1 (0.42) | CAPN9ALDH1A1MAPTMEN1KMT2A | |
| SCHEMBL879033 | 0.75 | CAPN9 (0.34) | CAPN9 | |
| SCHEMBL24198371 | 0.73 | PPM1B (0.37) | ALDH1A1MAPTMEN1CYP3A4CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1451278-B1 | ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2009-02-11 | — | — | EP | disclosed |
| US-7060664-B2 | Organic compounds | GIVAUDAN SA (CH) | 2006-06-13 | — | — | US | disclosed |
| US-20050119157-A1 | Organic compounds | GIVAUDAN SA (CH) | 2005-06-02 | — | — | US | disclosed |
| EP-1318190-A1 | Organic compounds | Givaudan SA (CH) | 2003-06-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050119157-A1 | Organic compounds | OR10J3, OR51E2, TRPA1 | CAPN9 3902/4885TRPM8 45/4885ALDH1A1 538/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.